Never Run Out Of Buyers To Sell To.

As of today, effective and safe treatment of bacterial endocarditis remains one of the last unmet medical needs in cardiology. devie medical transforms the treatment of bacterial endocarditis with an evolutionary transcatheter platform for drug delivery. By merging cutting edge medical technology with a proprietary pharmacological concept, we are not only defining the next frontier in an emerging therapeutic area, but pushing the boundaries for cardiovascular interventions.
Annual Revenue$1M to $5M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.